中国神经再生研究(英文版) ›› 2021, Vol. 21 ›› Issue (5): 1681-1697.doi: 10.4103/NRR.NRR-D-24-01344

• 综述:退行性病与再生 • 上一篇    下一篇

神经系统疾病中的乳酸和乳酸化修饰

  

  • 出版日期:2026-05-15 发布日期:2025-08-20
  • 基金资助:
    云南省应用基础研究联合基金项目(202301AY070001-200)、云南省高层次人才中青年学术技术带头人培养项目(202105AC160065)、云南神经与心血管疾病临床医学中心(YWLCYXZX2023300077、云南省神经病学重点临床专科(300064)。

Lactate and lactylation modifications in neurological disorders

Yu Gu, Keyang Chen, Chunyan Lei* , Xinglong Yang, Lu Wang, Linhu Zhao, Wen Jiang, Qionghua Deng   

  1. First Department of Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China
  • Online:2026-05-15 Published:2025-08-20
  • Contact: Chunyan Lei, MD, PhD, leichunyan328@163.com.
  • Supported by:
    This work was supported by Applied Basic Research Joint Fund Project of Yunnan Province, No. 202301AY070001-200; Middle-aged Academic and Technical Training Project for High-Level Talents, No. 202105AC160065; Yunnan Clinical Medical Center for Neurological and Cardiovascular Diseases, No. YWLCYXZX2023300077; and Key Clinical Specialty of Neurology in Yunnan Province, No. 300064 (all to CL)

摘要:

对不同靶器官中乳酸化修饰的研究已成为高度关注的焦点。大量的关键生命活动和疾病的发生不仅与蛋白质的丰度有关,更重要的是受蛋白质各种翻译后修饰的调控。传统上被视为无氧代谢副产物的乳酸已成为神经系统生理和病理过程中的重要能量底物和信号分子。最近的研究强调了它在各种神经系统疾病中的重要作用,包括阿尔茨海默病、帕金森病、急性缺血性脑卒中、多发性硬化、亨廷顿病和重症肌无力。此综述的目的是总结目前对神经系统疾病中乳酸和乳酰化修饰的认识,阐明其作用机制并确定潜在的治疗靶点。文章概述了乳酸在不同疾病中的代谢调节作用,强调了乳酸在脑功能调节中的参与。此外,文章还重点探讨了脑乳酸代谢的具体机制,强调了乳酸在调节脑功能方面的独特作用。作为乳酸功能的重要组成部分,文章详细介绍了乳酸化修饰,包括组蛋白和非组蛋白乳酸化,并重点介绍了在确定乳酸化书写器("writers")和擦除器("erasers")等关键调控酶方面取得的最新进展,总结了乳酸代谢异常在各种神经系统疾病中的影响和具体机制。此综述揭示了乳酸在大脑调节中作为信号分子的功能,以及乳酸代谢异常与各种神经系统疾病的进展有关。未来研究的重点应是进一步阐明乳酸和乳酰化修饰的分子机制,并探索其作为神经系统疾病治疗靶点的潜力。

https://orcid.org/0000-0003-4024-0896 (Chunyan Lei)

关键词: 星形胶质细胞-神经元乳酸穿梭理论, 脑乳酸代谢, 脑功能, 中枢神经系统, 组蛋白赖氨酸乳化, 单羧酸盐转运体, 神经系统, 神经退行性疾病, 非组蛋白赖氨酸乳化, 翻译后修饰

Abstract:

Research into lactylation modifications across various target organs in both health and disease has gained significant attention. Many essential life processes and the onset of diseases are not only related to protein abundance but are also primarily regulated by various post-translational protein modifications. Lactate, once considered merely a byproduct of anaerobic metabolism, has emerged as a crucial energy substrate and signaling molecule involved in both physiological and pathological processes within the nervous system. Furthermore, recent studies have emphasized the significant role of lactate in numerous neurological diseases, including Alzheimer’s disease, Parkinson’s disease, acute cerebral ischemic stroke, multiple sclerosis, Huntington’s disease, and myasthenia gravis. The purpose of this review is to synthesize the current research on lactate and lactylation modifications in neurological diseases, aiming to clarify their mechanisms of action and identify potential therapeutic targets. As such, this work provides an overview of the metabolic regulatory roles of lactate in various disorders, emphasizing its involvement in the regulation of brain function. Additionally, the specific mechanisms of brain lactate metabolism are discussed, suggesting the unique roles of lactate in modulating brain function. As a critical aspect of lactate function, lactylation modifications, including both histone and non-histone lactylation, are explored, with an emphasis on recent advancements in identifying the key regulatory enzymes of such modifications, such as lactylation writers and erasers. The effects and specific mechanisms of abnormal lactate metabolism in diverse neurological diseases are summarized, revealing that lactate acts as a signaling molecule in the regulation of brain functions and that abnormal lactate metabolism is implicated in the progression of various neurological disorders. Future research should focus on further elucidating the molecular mechanisms underlying lactate and lactylation modifications and exploring their potential as therapeutic targets for neurological diseases.

Key words: astrocyte-neuron lactate shuttle theory, brain functions, brain lactate metabolism, central nervous system, histone lysine lactylation, monocarboxylate transporters, nervous system, neurodegenerative diseases, non-histone lysine lactylation, post-translational modifications